Branched-chain amino acid supplementation in patients with liver diseases

Journal of Nutrition

Volumn 135, Issue 6 SUPPL., 2005, Pages

  Marchesini, Giulio ^a   Marzocchi, Rebecca ^a   Noia, Marianna ^a   Bianchi, Giampaolo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cirrhosis; Encephalopathy; Hepatocyte growth factor; Nitrogen balance; Nutrition; Survival

Indexed keywords

ALBUMIN; AMINO ACID; BRANCHED CHAIN AMINO ACID; CARBOHYDRATE; GLYCOGEN; LACTALBUMIN; LACTULOSE; MALTODEXTRIN; MUSCLE PROTEIN; NEOMYCIN; NITROGEN; PROTEIN; SCATTER FACTOR; SERUM ALBUMIN;

ANOREXIA; BLOOD BRAIN BARRIER; CATABOLISM; CHEMOEMBOLIZATION; CLINICAL TRIAL; CONFERENCE PAPER; DIET SUPPLEMENTATION; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER REGENERATION; LIVER TRANSPLANTATION; NITROGEN BALANCE; NUTRITION; PROGNOSIS; PROTEIN METABOLISM; PROTEIN SYNTHESIS; RADIOFREQUENCY ABLATION; SURVIVAL;

EID: 20344404975     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/135.6.1596s     Document Type: Conference Paper

References (50)

1. Müller, M. J., Seiberg, O. & Böker, K. (1994) Are patients with liver cirrhosis hypermetabolic? Clin. Nutr. 13: 131-144.
2. Plauth, M., Merli, M., Kondrup, J., Weimann, A., Ferenci, P., Muller, M. J. & for the ESPEN Consensus Group (1997) ESPEN guidelines for nutrition in liver disease and transplantation. Clin. Nutr. 16: 43-55.
3. Neuschwander-Tetri, B. A. & Caldwell, S. H. (2003) Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 37: 1202-1219.
4. Falck-Ytter, Y., Younossi, Z. M., Marchesini, G. & McCullough, A. J. (2001) Clinical features and natural history of nonalcoholic steatosis syndromes. Semin. Liver Dis. 21: 17-26.
5. Italian Multicentre Cooperative Project on nutrition In liver cirrhosis (1994) Nutritional status in cirrhosis. J. Hepatol. 21: 317-325.
6. Tajika, M., Kato, M., Mohri, H., Miwa, Y., Kato, T., Ohnishi, H. & Moriwaki, H. (2002) Prognostic value of energy metabolism in patients with viral liver cirrhosis. Nutrition 18: 229-234.
7. Marchesini, G., Bianchi, G., Amodio, P., Salerno, F., Merli, M., Panella, C., Loguercio, C., Apolone, G., Niero, M. & Abbiati, R. (2001) Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology 120: 170-178.
8. Selberg, O., Bottcher, J., Tusch, G., Pichlmayr, R., Henkel, E. & Muller, M. J. (1997) Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters In 150 patients. Hepatology 25: 652-657.
9. James, J. H., Ziparo, V., Jeppsson, B. & Fischer, J. E. (1979) Hyperammonaemia, plasma amino acid imbalance, and blood-brain amino acid transport: a unified theory of portal-systemic encephalopathy. Lancet 2: 772-775.
10. Naylor, C. D., O'Rourke, K., Detsky, A. S. & Baker, J. P. (1989) Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy. A meta-analysis. Gastroenterology 97: 1033-1042.
11. Fabbri, A., Magrini, N., Bianchi, G., Zoli, M. & Marchesini, G. (1996) Overview of randomized clinical trials of oral branched-chain amino acid treatment in chronic hepatic encephalopathy. J. Parenter. Enteral Nutr. 20: 159-164.
12. Als-Nielsen, B., Koretz, R. L., Kjaergard, L. L. & Gluud, C. (2004) Branched-chain amino acids for hepatic encephalopathy (Cochrane review). In: The Cochrane Library, Issue 2. John Wiley and Sons, Chichester, UK.
13. Ishiki, Y., Ohnishi, H., Muto, Y., Matsumoto, K. & Nakamura, T. (1992) Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 16: 1227-1235.
14. Tomiya, T., Inoue, Y., Yanase, M., Arai, M., Ikeda, H., Tejima, K., Nagashima, K., Nishikawa, T. & Fujiwara, K. (2002) Leucine stimulates the secretion of hepatocyte growth factor by hepatic stellate cells. Biochem. Biophys. Res. Commun. 297: 1108-1111.
15. Fenton, J. C., Knight, E. J. & Humpherson, P. L. (1966) Milk-and-cheese diet in portal-systemic encephalopathy. Lancet 1: 164-166.
16. Bianchi, G. P., Marchesini, G., Fabbri, A., Rondelli, A., Bugianesi, E., Zoli, M. & Pisi, E. (1993) Vegetable versus animal protein diet in cirrhotic patients with chronic encephalopathy. A randomized cross-over comparison. J. Intern. Med. 233: 385-392.
17. Rossi-Fanelli, F., Riggio, O., Cangiano, C., Cascino, A., De Conciliis, D., Merli, M., Stortoni, M., Giunchi, G. & Capocaccia, L. (1982) Branched-chain amino acids vs. lactulose in the treatment of hepatic coma. A controlled study. Dig. Dis. Sci. 27: 929-935.
18. Wahren, J., Denis, J., Desurmont, P., Eriksson, L. S., Esooffier, J. M., Gauthier, A. P., Hagenfeldt, L., Michel, H., Opolon, P., et al. (1983) Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study. Hepatology 3: 475-480.
19. Michel, H., Bories, P., Aubin, J. P., Pomier-Layrargues, G., Bauret, P. & Bellet-Herman, H. (1985) Treatment of acute hepatic encephalopathy in cirrhotics with a branched-chain amino acids enriched versus a conventional amino acids mixture. A controlled study of 70 patients. Liver 5: 282-289.
20. Cerra, F. B., Chung, N. K., Fischer, J. E., Kaplowitz, N., Schiff, E. R., Dienstag, J. L., Bower, R. H., Mabry, C. D., Leevy, C. M. & Kiernan, T. (1985) Disease-specific amino acid infusion (F080) in hepatic encephalopathy: a prospective, randomized, double-blind controlled trial. J. Parenter. Enteral Nutr. 9: 288-295.
21. Fiaccadori, F., Ghinelli, F., Pedretti, G., Pelosi, G., Sacchini, D., Zeneroli, M. L., Rocchi, E., Gibertini, P. & Ventura, E. (1985) Branched-chain enriched amino acid solutions in the treatment of hepatic encephalopathy: a controlled trial. Ital. J. Gastroenterol. 17: 5-10.
22. Strauss, E., dos Santos, W. R., da Silva, E. C., Lacet, C. M., Capacci, M.L.L. & Bernardini, A. P. (1986) Treatment of hepatic encephalopathy; a randomized clinical trial comparing branched chain enriched amino acid solution to oral neomycin. Nutr. Supp. Services 6: 18-21.
23. Vilstrup, H., Gluud, C., Hardt, F., Kristensen, M., Køler, O., Melgaard, B., Dejgaard, A., Hansen, B. E., Krintel, J. J., et al. (1990) Branched chain enriched amino acids versus glucose treatment of hepatic encephalopathy. A double-blind study of 65 patients with cirrhosis. J. Hepatol. 10: 291-296.
24. Eriksson, L. S., Persson, A. & Wahren, J. (1982) Branched-chain I amino acids in the treatment of chronic hepatic encephalopathy. Gut 23: 801-806.
25. Sieg, A., Walker, S., Czygan, P., Gärtner, U., Lanzinger-Rossnagel, G., A., S. & Kommerell, B. (1983) Branched-chain amino acid-enriched elemental diet in patients with cirrhosis of the liver. Z. Gastroenterol. 21: 644-650.
26. Simko, V. (1983) Long-term tolerance of a special amino acid oral formula in patients with advanced liver disease. Nutr. Rep. Int. 27: 765-773.
27. McGhee, A., Henderson, M., Millikan, W. J., Bleier, J. C., Vogel, R., Kassouny, M. & Rudman, D. (1983) Comparison of the effects of Hepatic-Aid and a casein modular diet on encephalopathy, plasma amino acids, and nitrogen balance in cirrhotic patients. Ann. Surg. 197: 288-293.
28. Horst, D., Grace, N. D., Conn, H. O., Schiff, E., Schencker, S., Viteri, A., Law, D. & Atterbury, C. E. (1984) Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy. Hepatology 4: 279-287.
29. Guarnieri, G. F., Toigo, R., Situlin, R., Pozzato, G., Faccini, L., Marini, R., Giuntini, D., Parco, S., Lucchesi, A., et al. (1984) Muscle biopsy study on malnutrition in patients with liver cirrhosis. In: Hepatic Encephalopathy in Chronic Liver Failure (Capocaccia, L., Fischer, J. E. & Rossi-Fanelli, F., eds.), pp. 193-209. Plenum Press, New York, NY.
30. Christie, M. L., Sack, D. M., Pomposelli, J. & Horst, H. (1985) Enriched branched-chain amino acid formula vs. a casein-based supplement in the treatment of cirrhosis. J. Parenter. Enteral Nutr. 9: 671-678.
31. Egberts, E. H., Schomerus, H., Hamster, W. & Jürgens, P. (1985) Branched chain amino acids in the treatment of latent portosystemic encephalopathy. A double-blind placebo-controlled cross-over study. Gastroenterology 88: 887-895.
32. Fiaccadori, F., Elia, G. F., Lehndorff, H., Merli, M., Pedretti, G., Riggio, O. & Capocaccia, L. (1988) The effect of dietary supplementation with branched-chain amino acids vs. casein in patients with chronic recurrent portal systemic encephalopathy: a controlled trial. In: Advances in Ammonia Metabolism and Hepatic Encephalopathy (Soeters, P. B., Wilson, J.H.P., Meijer, A. J. & Holm, E., eds.), pp. 489-497. Excerpta Medica, Amsterdam, The Netherlands.
33. Swart, G. R., van den Berg, W. O., van Vuure, J. K., Rietveld, D., Wattimena, D. L. & Frenkel, M. (1989) Minimum protein requirements in liver cirrhosis determined by nitrogen balance measurements at three levels of protein intake. Clin. Nutr. 8: 329-336.
34. Marchesini, G., Dioguardi, F. S., Bianchi, G. P., Zoli, M., Bellati, G., Roffi, L., Martines, D., Abbiati, R. & the Italian Multicenter Study Group. (1990) Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. J. Hepatol. 11: 92-101.
35. Marchesini, G., Bianchi, G., Merli, M., Amodio, P., Panella, C., Loguercio, C., Rossi Fanelli, F. & Abbiati, R. (2003) Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology 124: 1792-1801.
36. Chawla, R. K., Wolf, D. C., Kutner, M. H. & Bonkovsky, H. L. (1989) Choline may be an essential nutrient in malnourished patients with cirrhosis. Gastroenterology 97: 1514-1520.
37. Lieber, C. S. (2000) Alcoholic liver disease: new insights in pathogenesis lead to new treatments. J. Hepatol. 32: 113-128.
38. Marsano, L. & McClain, C. J. (1991) Nutrition and alcoholic liver disease. J. Parenter. Enteral Nutr. 15: 337-344.
39. Marchesini, G., Bianchi, G., Lucidi, P., Villanova, N., Zoli, M. & De Feo, P. (2004) Plasma ghrelin concentrations, food intake, and anorexia in liver failure. J. Clin. Endocrinol. Metab. 89: 2136-2141.
40. Merli, M., Nicolini, G., Angeloni, S. & Riggio, O. (2002) Malnutrition is a risk factor in cirrhotic patients undergoing surgery. Nutrition 18: 978-986.
41. Fan, S. T., Lo, C. M., Lai, E. C., Chu, K. M., Liu, C. L. & Wong, J. (1994) Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N. Engl. J. Med. 331: 1547-1552.
42. The San-in Group of Liver Surgery (1997) Long-term oral administration of branched chain amino acids after curative resection of hepatocellular carcinoma: a prospective randomized trial. Br. J. Surg. 84: 1525-1531.
43. Poon, R. T., Yu, W. C., Fan, S. T. & Wong, J. (2004) Long-term oral branched chain amino acids in patients undergoing chemoembolization for hepatocellular carcinoma: a randomized trial. Aliment. Pharmacol. Ther. 19: 779-788.
44. Chin, S. E., Shepherd, R. W., Thomas, B. J., Cleghorn, G. J., Patrick, M. K., Wilcox, J. A., Ong, T. H., Lynch, S. V. & Strong, R. (1992) Nutritional support in children with end-stage liver disease: a randomized crossover trial of a branched-chain amino acid supplement. Am. J. Clin. Nutr. 56: 158-163.
45. Reilly, J., Mehta, R., Teperman, L., Cemaj, S., Tzakis, A., Yanaga, K., Ritter, P., Rezak, A. & Makowka, L. (1990) Nutritional support after liver transplantation: a randomized prospective study. J. Parenter. Enter Nutr. 14: 386-391.
46. Bilbao, I., Armadans, L., Lazaro, J. L., Hidalgo, E., Castells, L. & Margarit, C. (2003) Predictive factors for early mortality following liver transplantation. Clin. Transplant. 17: 401-411.
47. Luzi, L., Perseghin, G., Regalia, E., Sereni, L. P., Battezzati, A., Baratti, D., Bianchi, E., Terruzzi, I., Hilden, H., et al. (1997) Metabolic effects of liver transplantation in cirrhotic patients. J. Clin. Invest. 99: 692-700.
48. Tietge, U. J., Bahr, M. J., Manns, M. P. & Boker, K. H. (2003) Hepatic amino-acid metabolism in liver cirrhosis and in the long-term course after liver transplantation. Transpl. Int. 16: 1-8.
49. Ijichi, C., Matsumura, T., Tsuji, T. & Eto, Y. (2003) Branched-chain amino acids promote albumin synthesis in rat primary hepatocytes through the mTOR signal transduction system. Biochem. Biophys. Res. Commun. 303: 59-64.
50. Charlton, M. (2003) Branched-chain amino acid-enriched supplements as therapy for liver disease: Rasputin lives. Gastroenterology 124: 1980-1982.